Coherus BioSciences与强生公司已达成协议,双方将各自保留其研发化合物的全部商业化权利。这一安排明确了各自的知识产权归属和未来市场开发路径,为双方后续的独立商业运作奠定了基础。
Coherus BioSciences与强生公司已达成协议,双方将各自保留其研发化合物的全部商业化权利。这一安排明确了各自的知识产权归属和未来市场开发路径,为双方后续的独立商业运作奠定了基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.